£2.5M
The oversubscribed financing was led by Ahren Innovation Capital and will support preclinical validation and platform development.
OutSee
Genomics and drug discovery company leveraging artificial intelligence for target identification.
£4.3MTotal raised
OutSee is a genomics and drug discovery company that uses predictive AI to identify therapeutic targets. The firm applies its Nomaly platform to precision medicine and target discovery.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from OutSee's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
Investors
- £2.5M
- £1.8M
Funding history
£1.8M
The financing round was led by Ahren Innovation Capital and will support the expansion of the company's in-house target discovery programme.